SREBP1c and FOXO have been reported to play a role in transcriptional regulation of metabolism at high glucose levels, FOXO-1 in cardiac pathology in diabetes mellitus, PPARγ in lipid metabolism, and PPARs in cardiac dysfunction in diabetic cardiomypathy36–38. This evidence concerns the gene SREBF1 and diabetes mellitus.